Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics

N Ebrahimi, S Aslani, F Babaie… - International …, 2020 - Elsevier
… clinical manifestations in Coronavirus disease-2019 (COVID-19). … the pathological
manifestations of COVID-19. Lethal forms of … Current therapeutic approach for COVID-19 is in favor …

COVID19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: potential targets and challenges

A Pourgholaminejad… - Scandinavian Journal …, 2022 - Wiley Online Library
therapeutic approach for COVID-19 patients (clinicaltrials.gov). A paracrine mechanism of
MSCs is entails the secretion of EVs, which are classified into microvesicles, exosomes and …

A 21st century evil: immunopathology and new therapies of COVID-19

TF Silva, F Tomiotto-Pellissier, RA Sanfelice… - Frontiers in …, 2020 - frontiersin.org
… thoroughly considered as a COVID-19 therapeutic strategy. … relevance in the pathogenesis
of COVID-19. The induction of … with COVID-19 and has a central role in the pathogenesis of …

Cytokine storm in COVID-19—immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper

S Bhaskar, A Sinha, M Banach, S Mittoo… - Frontiers in …, 2020 - frontiersin.org
… important to the pathogenesis of several severe manifestations of COVID-19: acute … for
COVID-19 patients, including the risk factors for cytokine storm, potential therapeutic strategies (6)…

Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective

A Mardi, S Meidaninikjeh, S Nikfarjam… - Viral …, 2021 - liebertpub.com
… system and immunopathogenesis of COVID-19. Furthermore, … and decreasing the rate of
mortality in COVID-19 patients. … therapeutic strategies can reduce the mortality rate in COVID-…

[HTML][HTML] Advances in pathogenesis, progression, potential targets and targeted therapeutic strategies in SARS-CoV-2-Induced COVID-19

H Zhou, WJ Ni, W Huang, Z Wang, M Cai… - Frontiers in …, 2022 - frontiersin.org
… Currently, there are only a few clinically approved drugs, vaccines and corresponding
therapeutic strategies for COVID-19, and we cannot control the long-term consequences. …

[HTML][HTML] The role of CD4+ FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment

Y Wang, J Zheng, MS Islam, Y Yang… - International journal of …, 2021 - ncbi.nlm.nih.gov
… Tregs in the immunopathology of COVID-19. The emerging concept of Treg-targeting therapies,
… -boosting effect of therapeutic agents used in the treatment of COVID-19 is analyzed. We …

[HTML][HTML] Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy

L Iovino, LA Thur, S Gnjatic, A Chapuis… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
… involved in the pathogenesis of COVID-19, especially by … therapies are currently under
investigation and may lead to a reduction in hospitalization and mortality due to COVID-19

Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …

AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
… of COVID-19. Furthermore, the immunomodulatory therapeutic strategies are also discussed
to … and treat the cytokine storm or hypercytokinemia in critically ill patients with COVID-19. …

Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies

PM Varghese, AG Tsolaki, H Yasmin, A Shastri… - Immunobiology, 2020 - Elsevier
… The current coronavirus pandemic, COVID-19, is the third outbreak of disease caused by
the coronavirus family, after Severe Acute Respiratory Syndrome and Middle East Respiratory …